Petro TERBLANCHE
CEO, Afrigen Biologics & Vaccines
Professor Petro Terblanche has played a key part in the design and implementation of South Africa’s biotechnology strategy. She holds the position of Chief Executive Officer of Afrigen Biologics (Pty)Ltd based in Cape Town, South Africa. Afrigen hosts the WHO Global mRNA technology development and transfer Hub and has a mRNA Covid 19 vaccine candidate in development as part of a global program to build capacity and capabilities in LMICs to design, develop and produce mRNA vaccines. A considerable part of her career was in research, development and innovation at the South African Medical Research Council (SAMRC) as well as the Council for Scientific and Industrial Research (CSIR). She has held and holding several strategic public and private sector Board positions in SA as well as the position as President of the Stakeholders Organization for the Global Alliance for TB Drug Discovery and Development (2007-2010).